Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[Q]: Paragraph: Up to 94 students will get scholarships on campuses in Phoenix and Tucson, the UA Colleges of Medicine said. For each year of tuition waived, they’ll have to commit to working in an underserved area after their residency for one year. The scholarships are funded with $3 million from an $8 million state funding plan approved earlier this year. The rest of that money will allow growth from 80 to 100 medical students at UA’s Phoenix campus. State and federal governments have looked to a wide variety of grants, scholarships, loan forgiveness and other initiatives to seek out doctors willing to work in underserved areas and support them financially. An aging population and projected physician retirements have fueled concerns that the U.S. will face a growing shortage of providers — a problem felt hardest in lower-income areas. Physician groups say high debt burdens discourage new doctors from working in primary care in rural or urban underserved areas, which tend to come with lower salaries than jobs in specialties or wealthy areas. Debt concerns discourage some would-be doctors from even applying to medical school, Dr. Michael Dake, senior vice president of UA Health Sciences, said in a news release. The scholarships will be available only to UA students who qualify as Arizona residents. Eligible post-residency specializations include family medicine, general internal medicine, geriatrics, pediatrics, psychiatry, and obstetrics and gynecology. Eligible underserved areas are designated by the federal government based on having too few doctors, high infant mortality rates, high poverty or a large elderly population. UA medical school tuition for Arizona residents is about $33,000 per year. Medical school is four years. Arizona’s physician training capacity has grown in recent years with the opening of the UA’s Phoenix campus and schools run by the Mayo Clinic in Scottsdale, A.T. Still University in Mesa and Midwestern University in Glendale. Nebraska-based Creighton University is building a health sciences campus that will include a medical school in midtown Phoenix. Claim: Scholarships target doctors in Arizona underserved areas.
[A]: University of Arizona’s medical school announced Friday that it will give free tuition to some students who commit to working as primary care doctors in underserved areas, an effort to improve access to health care in areas where it’s most lacking.


[Q]: Paragraph: Shares of the company traded marginally down at $132.47, after having closed up 1.7% on Monday. (bit.ly/2ZkZGze)    J&J said that the FTC had issued a “civil investigative demand,” or CID, the equivalent of a subpoena to determine if the contracting practices were legal. Pfizer Inc filed a lawsuit against J&J in 2017, saying its rival’s contracts with health insurers for blockbuster rheumatoid arthritis drug, Remicade, were anticompetitive and aimed at blocking sales of Pfizer’s biosimilar called Inflectra. Pfizer said in the lawsuit that J&J had contracted with many insurers to give discounts in exchange for giving preference to Remicade, and to only pay for Inflectra in cases where Remicade proved to be ineffective. Inflectra was approved in 2016 while Remicade went on the market in 1998. Remicade is an infused treatment for chronic autoimmune disorders and costs about $4,000 per dose, or $26,000 a year, Pfizer said in the lawsuit. J&J has denied any wrongdoing and is fighting the Pfizer lawsuit. Pfizer said in a statement that it had received a CID in June. “As Pfizer’s complaint alleges, J&J’s unlawful conduct is designed to prevent Inflectra from being able to compete on its primary point of differentiation – price. Today, Inflectra has an average selling price (ASP) that is more than 22% lower than Remicade,” the company said in a statement. “Despite these facts, J&J has not lost substantial volume or share of sales – counter to what should occur in a competitive market.”  Biosimilars are intended to be lower-cost alternatives to expensive biotech medicines. But since they are made from living cells and it is not possible to make an exact copy of the branded medicine, they are not automatically substituted for the existing branded drug the way a generic drug would be. The drugs treat ailments like rheumatoid arthritis, Crohn’s disease and ulcerative colitis. Claim: J&J says FTC probing efforts to protect arthritis drug Remicade.
[A]: The Federal Trade Commission issued civil subpoenas to Johnson and Johnson in June as part of an investigation into whether contracting practices for its blockbuster rheumatoid arthritis drug, Remicade, violated antitrust laws, the company said in a regulatory filing on Monday.


[Q]: Paragraph: A developmental biologist and tissue engineer, Dr. Mironov, 56, is one of only a few scientists worldwide involved in bioengineering “cultured” meat. It’s a product he believes could help solve future global food crises resulting from shrinking amounts of land available for growing meat the old-fashioned way ... on the hoof. Growth of “in-vitro” or cultured meat is also under way in the Netherlands, Mironov told Reuters in an interview, but in the United States, it is science in search of funding and demand. The new National Institute of Food and Agriculture, part of the U.S. Food and Drug Administration, won’t fund it, the National Institutes of Health won’t fund it, and the National Aeronautics and Space Administration funded it only briefly, Mironov said. “It’s classic disruptive technology,” Mironov said. “Bringing any new technology on the market, average, costs $1 billion. We don’t even have $1 million.”   Director of the Advanced Tissue Biofabrication Center in the Department of Regenerative Medicine and Cell Biology at the medical university, Mironov now primarily conducts research on tissue engineering, or growing, of human organs. “There’s a yuck factor when people find out meat is grown in a lab. They don’t like to associate technology with food,” said Nicholas Genovese, 32, a visiting scholar in cancer cell biology working under a People for the Ethical Treatment of Animals three-year grant to run Dr. Mironov’s meat-growing lab. “But there are a lot of products that we eat today that are considered natural that are produced in a similar manner,” Genovese said. “There’s yogurt, which is cultured yeast. You have wine production and beer production. These were not produced in laboratories. Society has accepted these products.”   If wine is produced in winery, beer in a brewery and bread in a bakery, where are you going to grow cultured meat? In a “carnery,” if Mironov has his way. That is the name he has given future production facilities. He envisions football field-sized buildings filled with large bioreactors, or bioreactors the size of a coffee machine in grocery stores, to manufacture what he calls “charlem” — “Charleston engineered meat.”   “It will be functional, natural, designed food,” Mironov said. “How do you want it to taste? You want a little bit of fat, you want pork, you want lamb? We design exactly what you want. We can design texture. “I believe we can do it without genes. But there is no evidence that if you add genes the quality of food will somehow suffer. Genetically modified food is already normal practice and nobody dies.”   Dr. Mironov has taken myoblasts — embryonic cells that develop into muscle tissue — from turkey and bathed them in a nutrient bath of bovine serum on a scaffold made of chitosan (a common polymer found in nature) to grow animal skeletal muscle tissue. But how do you get that juicy, meaty quality? Genovese said scientists want to add fat. And adding a vascular system so that interior cells can receive oxygen will enable the growth of steak, say, instead of just thin strips of muscle tissue. Cultured meat could eventually become cheaper than what Genovese called the heavily subsidized production of farm meat, he said, and if the public accepts cultured meat, the future holds benefits. “Thirty percent of the earth’s land surface area is associated with producing animal protein on farms,” Genovese said. “Animals require between 3 and 8 pounds of nutrient to make 1 pound of meat. It’s fairly inefficient. Animals consume food and produce waste. Cultured meat doesn’t have a digestive system. “Further out, if we have interplanetary exploration, people will need to produce food in space and you can’t take a cow with you. “We have to look to these ideas in order to progress. Otherwise, we stay static. I mean, 15 years ago who could have imagined the iPhone?” Claim: South Carolina scientist works to grow meat in lab.
[A]:
In a small laboratory on an upper floor of the basic science building at the Medical University of South Carolina, Vladimir Mironov, M.D., Ph.D., has been working for a decade to grow meat.